I think that the previous answers work to describe the idea of CAPA well. It’s basically saying that you will not make the same mistake twice. If you know something is not functioning correctly or well and you continue to do it wrong, it would make sense the FDA (or governmental figure) would not be willing to overlook. In a way, it is a protection against a much bigger problem. It helps you minimize risk and prevent a lawsuit and loss of customers.